SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Shaperon Inc. (378800.KQ) News

Track canonical SquawkNews coverage tagged to 378800.KQ, Shaperon Inc.. This hub brings together deduplicated headlines about kosdaq, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 378800.KQ Asset equity Sector Markets 90 days 1 Last 2,490 Updated Sep 30, 2026, 12:25 PM UTC Open live news feed
M Shaperon HY209 gel misses primary endpoint in phase 2 atopic dermatitis trial Final clinical study report confirms the trial missed its main efficacy goal versus placebo. Secondary readouts showed limited, inconsistent benefit and no clear dose-response pattern. EQUITY | Sep 30, 2026, 12:25 PM UTC